Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
G He, G He, R Zhou, Z Pi, T Zhu, L Jiang… - … and biophysical research …, 2016 - Elsevier
Cisplatin-based therapy is one of the most important chemotherapy treatments for cancers.
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo.
G He, R Zhou, Z Pi, T Zhu, L Jiang… - … and Biophysical Research …, 2015 - europepmc.org
Cisplatin-based therapy is one of the most important chemotherapy treatments for cancers.
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
G He, G He, R Zhou, Z Pi, T Zhu… - Biochemical and …, 2016 - pubmed.ncbi.nlm.nih.gov
Cisplatin-based therapy is one of the most important chemotherapy treatments for cancers.
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo
G He, G He, R Zhou, Z Pi, T Zhu, L Jiang… - … and Biophysical Research …, 2016 - infona.pl
Cisplatin-based therapy is one of the most important chemotherapy treatments for cancers.
However, its efficacy is greatly limited by drug resistance and undesirable side effects …
However, its efficacy is greatly limited by drug resistance and undesirable side effects …